Keep an Eye on News Updates: Dont feel the need to obsess over it, but it doesnt hurt to keep an eye out for any updates the FDA shares in case the medication landscape shifts
Notably, as these studies were largely open-label with varying intensities of lifestyle intervention and control conditions, they are better suited as evidence for strategic feasibility rather than as direct equivalents to placebo-controlled trials
When to Contact Your Doctor About This Combination Notify your prescribing physician immediately if you experience elevated blood sugar readings, severe appetite increase, dizziness, or unexplained weight gain after starting prednisone while on semaglutide
Quick Answer: GLP-1 receptor agonists are being investigated for potential neuroprotective effects in Alzheimer's disease, but they are not FDA-approved for dementia prevention or treatment
Kinetic and X-ray [PMID: 6697994] Laboratory literature summary: Interaction of a glutathione S-conjugate with glutathione reductase